Association of dialysis facility-level hemoglobin measurement and erythropoiesis-stimulating agent dose adjustment frequencies with dialysis facility-level hemoglobin variation: a retrospective analysis
<p>Abstract</p> <p>Background</p> <p>A key goal of anemia management in dialysis patients is to maintain patients' hemoglobin (Hb) levels consistently within a target range. Our aim in this study was to assess the association of facility-level practice patterns rep...
Main Authors: | Kothawala Anupam, Krishnan Mahesh, Khan Irfan, Ashfaq Akhtar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Nephrology |
Online Access: | http://www.biomedcentral.com/1471-2369/12/22 |
Similar Items
-
Temporal Trends in Hemoglobin, Use of Erythropoiesis Stimulating Agents, and Major Clinical Outcomes in Incident Dialysis Patients in Canada
by: Mark Canney, et al.
Published: (2021-04-01) -
Should we adjust erythropoiesis-stimulating agent dosage to postdialysis hemoglobin levels? A pilot study
by: Castillo Nieves, et al.
Published: (2012-07-01) -
The relationship between hemoglobin level with PTH level and dialysis adequacy in chronic hemodialysis patients
by: Ziba Aghsaiefard, et al.
Published: (2018-07-01) -
The Effect of Pentoxyfiline on Hemoglobin and the Dose of Erythropoietin in Anamic Peritoneal Dialysis Patients
by: Mojgan Mortazavi, et al.
Published: (2011-03-01) -
Serum Hepcidin Levels and Reticulocyte Hemoglobin Concentrations as Indicators of the Iron Status of Peritoneal Dialysis Patients
by: Aya Eguchi, et al.
Published: (2012-01-01)